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Abstract
Microglia are brain-resident macrophages forming the first active
immune barrier in the central nervous system. They fulfill multiple
functions across development and adulthood and under disease
conditions. Current understanding revolves around microglia
acquiring distinct phenotypes upon exposure to extrinsic cues in
their environment. However, emerging evidence suggests that
microglia display differences in their functions that are not exclu-
sively driven by their milieu, rather by the unique properties these
cells possess. This microglial intrinsic heterogeneity has been
largely overlooked, favoring the prevailing view that microglia are
a single-cell type endowed with spectacular plasticity, allowing
them to acquire multiple phenotypes and thereby fulfill their
numerous functions in health and disease. Here, we review the
evidence that microglia might form a community of cells in which
each member (or “subtype”) displays intrinsic properties and
performs unique functions. Distinctive features and functional
implications of several microglial subtypes are considered, across
contexts of health and disease. Finally, we suggest that microglial
subtype categorization shall be based on function and we propose
ways for studying them. Hence, we advocate that plasticity (reac-
tion states) and diversity (subtypes) should both be considered
when studying the multitasking microglia.
Keywords disease; heterogeneity; homeostasis; microglia; subtypes
DOI 10.15252/embj.2019101997 | Received 13 March 2019 | Revised 29 April
2019 | Accepted 3 May 2019 | Published online 2 August 2019
The EMBO Journal (2019) 38: e101997
Introduction
Microglia were introduced to the scientific literature a century ago
(Rı´o-Hortega, 1919a,b,c; Fig 1). During normal physiological condi-
tions, microglial cells with a ramified morphology are regularly
distributed throughout the central nervous system (CNS; Rı´o-Hortega,
1919b). Upon pathology, microglia transform their morphology and
function, leading to propose a cascade of “reaction” from ramified to
hypertrophic and ameboid phenotypes that still orients research today
(Flanary et al, 2007; Graeber, 2010; Fig 1). With the recent advances
in genetic tools allowing for fate mapping (Ginhoux et al, 2010),
microglia are now considered to be tissue-resident macrophages of the
CNS that arise exclusively from the embryonic yolk sac (Alliot et al,
1999; Schulz et al, 2012; Kierdorf et al, 2013; Perdiguero et al, 2015).
Microglia colonize the murine CNS from embryonic day (E)9.5 (Tay
et al, 2017c) and represent a self-maintaining and long-lived cell
population that persists for months, if not the entire lifespan of the
organism (Lawson et al, 1992; Ajami et al, 2007, 2011; Mildner et al,
2007; Askew et al, 2017; Fu¨ger et al, 2017; Re´u et al, 2017; Tay et al,
2017b). Beyond microglia functioning as mediators of injury,
inflammation, and neurodegeneration, several roles in the healthy
brain have been identified at an exponential rate this past decade
(Cartier et al, 2014; Tremblay et al, 2015; Fig 1).
Microglia exhibit widely differing functions depending on the
stage of life, CNS region, and context of health or disease. Dif-
ferences in microglial number, morphology, and gene expression
were also reported between sexes (Schwarz et al, 2012; Crain et al,
2013; Lenz et al, 2013; Pimentel-Coelho et al, 2013; Butovsky et al,
2015; Dorfman et al, 2017; Hanamsagar et al, 2017; Krasemann
et al, 2017). Adequate microglial functions are crucial for plasticity
and behavioral adaptation to the environment (Salter & Stevens,
2017; Tay et al, 2017a). Throughout life, microglia contribute to
neurogenesis, neuronal circuit shaping, vascular formation and
remodeling, and maintenance of homeostasis (Tay et al, 2017c).
During aging and in diseases, these cells may become reactive or
impaired in their surveillance and phagocytosis (Streit, 2002; Koell-
hoffer et al, 2017; Spittau, 2017). Microglial contribution to diseases
is associated with compromised physiological roles (e.g., in synaptic
maintenance and plasticity; Tay et al, 2017a) and processes that are
adaptive in the healthy brain, yet leading to cell death and tissue
damage in pathological settings (e.g., excitotoxicity, oxidative stress,
and inflammation; Weil et al, 2008). Microglial reaction can be trig-
gered by any kind of insults or disturbances to the CNS. Persisting
microglial reaction, associated often with proliferation, is involved
in pathological conditions ranging from neurodevelopmental disor-
ders, traumatic injuries, infectious diseases, tumors, and psychiatric
disorders, to neurodegenerative diseases.
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Depending on the stage of the life, CNS region, and stressor or
pathological insult at play, the microglial reaction process was
shown to proceed differently and to result in sometimes contrasting
outcomes (see Fig 2A for a classical schematic representation,
depicting a ramified gray microglial cell surrounded by a palette of
colorful microglia each representing a distinct reaction state). It is
also now recognized that microglia display a wide range of reaction
states, a tremendous shift from the M1/M2 classification still used a
few years ago (Martinez & Gordon, 2014; Ransohoff, 2016). Accord-
ing to this view, the numerous functions of microglia would be ful-
filled through their reaction toward multiple phenotypes, each
associated with a distinct molecular signature (Crain et al, 2013;
Hickman et al, 2013; Butovsky et al, 2014; Bennett et al, 2016;
Grabert et al, 2016; Flowers et al, 2017; Galatro et al, 2017; Keren-
Shaul et al, 2017; Krasemann et al, 2017; Hammond et al, 2018;
Masuda et al, 2019). However, several pieces of evidence also indi-
cate that different pools of microglia might each display distinct
intrinsic properties that would be acquired during their maturation
or function within the CNS. These subtypes would co-exist at steady
state and undergo further modulation or phenotypic transformation
in response to stimuli (Fig 2B). Indeed, beyond the view that micro-
glia are a unique cell type in the CNS that adopts different pheno-
types in response to different stimuli, we propose in this review
article that microglia might constitute a community of cells in which
different members display distinct properties, perform distinct phys-
iological functions, and respond differently to stimuli (Fig 2C). We
review the distinctive features of several putative microglial
“subtypes”, at structural, ultrastructural, and expression levels, as
well as their functional implications across contexts of health and
disease. Furthermore, we propose to categorize microglial subtypes
based on functions, rather than molecular signatures and markers.
Finally, we suggest that microglial subtype candidates should be
validated using a methodological workflow that we recommend.
Microglia: a community fulfilling the vast
microglial functions
What defines a cell subtype is subject of intense debate, and it is
discussed in Box 1. Accumulating evidence indicates that microglia
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Figure 1. Historical overview of microglial subtype identification.
Although microglial subtypes have originally been proposed by Rio-Hortega in the first report of microglia, it was only recently that this idea was revisited.
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are not the naı¨ve cell type that invariably responds identically to
any possible type of stimuli by assuming a predetermined pheno-
type. In fact, from a historical perspective, the notion of microglial
subtypes had already been proposed in 1919 by Rio-Hortega in his
original description of microglia (Rı´o-Hortega, 1919b; Fig 1). He
noticed that some microglia that he named “satellite” microglia
were found in close proximity to neuronal cell bodies. A century
later, we propose that the satellite microglia, which are discussed
below, might represent one of the playing cards in the deck of
microglial subtypes (Fig 3). It is important to acknowledge that
others, avant-garde scientists, have paved the way for the concept
of microglial diversity (McCluskey & Lampson, 2000; Olah et al,
2011; Hanisch, 2013; Gertig & Hanisch, 2014).
Microglial regional heterogeneity at steady state
Although microglia are ubiquitously scattered throughout the CNS,
their distribution varies across regions, also between the white
matter and gray matter (Lawson et al, 1990). Microglial morphology
differs with the presence of neuronal cell bodies, dendrites and
axons, myelinated axons, and blood vessels. Furthermore, microglia
exhibit regional differences in self-renewal and turnover rates under
normal physiological conditions and upon stimuli, such as
lipopolysaccharide (LPS) challenge (Lawson et al, 1992; Ajami et al,
2007, 2011; Mildner et al, 2007; Askew et al, 2017; Fu¨ger et al,
2017; Re´u et al, 2017; Tay et al, 2017b; Furube et al, 2018). The
regional microenvironment has been shown to tightly determine
microglial identity at the transcriptional level, in both mouse and
human (Gosselin et al, 2014, 2017). Direct evidence for microglial
regional variability notably comes from studies in which microglia
were isolated from wild-type, unchallenged adult mice, according to
brain area, and their transcriptome was determined based on panels
of pre-selected microglial markers. In one study, the expression of
CD11b, CD40, CD45, CD80, CD86, F4/80, TREM2b, CX3CR1, and
CCR9 was compared among microglia isolated from different CNS
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Figure 2. Microglial reaction states.
(A) Currently, microglia are considered a homogenous cellular population (core of the circle in gray) that is extremely plastic. Depending on the brain homeostasis status at a
given developmental stage or resulting from pathology, microglia respond invariably to assume a wide range of phenotypes as described in the literature. (B) In the updated
version proposed here, microglia constitute a heterogeneous cell population having intrinsic properties and functional specializations. (C) Upon an environmental cue, each
microglial subtype may respond or not to the stimulus, by expanding and/or changing its morphology and gene expression to assume a specific phenotype.
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regions of young adult mice (de Haas et al, 2008). Although all of
these markers were expressed across the CNS, their protein expres-
sion varied significantly between areas. In a similar study performed
in adult rats, the expression levels of known microglial markers also
showed region-specific profiles (Doorn et al, 2015). Similar studies
performed in mice that compared microglia isolated from different
brain areas additionally showed regional heterogeneity in expres-
sion pattern throughout the lifespan (Butovsky et al, 2014; Grabert
et al, 2016; De Biase et al, 2017; Masuda et al, 2019). Additionally,
in an unbiased single-cell RNA sequencing (RNAseq) study, in
which cerebral tissue and hippocampal tissue from unchallenged
young adult mice were analyzed, 47 molecularly distinct cell
subtypes were identified, including two belonging to the microglia
(Zeisel et al, 2015).
These findings raise the intriguing possibility that regional dif-
ferences in terms of neuronal survival, activity, growth factor
release, metabolism, as well as synaptic plasticity, myelination,
vascular remodeling, blood–brain barrier properties, may require
distinct microglial functions, thus driving the differentiation of
distinct microglial subtypes during development or function within
the CNS. These microglial subtypes could be a major contributing
factor to the microglial regional heterogeneity. Recently, cerebellar
microglia were shown to display a unique clearance ability, defined
by their expression of numerous genes supporting the engulfment
and catabolism of cells or cellular debris (Ayata et al, 2018). This
cerebellar microglial “type” is reminiscent of developing microglia
and disease-associated microglia (DAM) that will be discussed
below. By contrast, microglia from the striatum display a homeo-
static surveillance phenotype. This microglial differentiation in
response to regional differences in the environment was shown to
be driven by epigenetic mechanisms (Ayata et al, 2018). In particu-
lar, the suppression of clearance genes in striatal microglia is medi-
ated by PRC2, which catalyzes the repressive chromatin
modification histone H3 lysine 27 trimethylation (H3K27me3). The
ablation of PRC2 in microglia also results in the emergence of clear-
ance microglia even in the absence of dying neurons, among both
the striatum and cerebral cortex. These aberrant clearance microglia
induce impaired motor responses, decreased learning and memory,
together with the development of anxiety and seizures in mice
(Ayata et al, 2018). A recent study that characterized the diversity
of CNS-associated macrophages (CAM) also identified three dif-
ferent subsets of CAM that expressed high levels of Mrc1, Ms4at,
Pf4, Stab1, Cbr2, CD163, and Fcrls, and were associated with dif-
ferent CNS compartments: the leptomeninges, choroid plexus, and
perivascular space (Jorda˜o et al, 2019). Consequently, some of the
regional microglial diversity described using these markers could
also be partly accounted for by CAM diversity.
Microglial subtypes as defined by differential gene expressions
Differential gene expression is an established approach for defining
distinct subpopulations of a cell type, for instance the different
neuronal subtypes (e.g., GABAergic and glutamatergic) observed in
the healthy brain. In various contexts, neighboring microglia were
shown to display differences in gene expression at steady state.
These observed differences between microglia could arise from local
cues, including interactions with different subtypes of neurons (e.g.,
inhibitory and excitatory) and glial cells (astrocytes, oligodendro-
cytes, and progenitors), or slight differences in signaling thresholds.
Box 1: How to define a “cell (sub)type”
The answer to “how to define a cell subtype?” is probably to be found in the answer to a closely related question, “how to define a cell type?” Traditionally, a
cell type is defined based on its host tissue, morphology, lineage, function, and molecular composition. However, the definition of this term remains subject
to intense debate (Clevers et al, 2017). The advancement of unbiased technologies for single-cell transcriptome profiling, such as high throughput single-cell
RNAseq and mass cytometry (or improved/related methods), has revealed remarkable heterogeneity among cells which were traditionally considered to be
homogeneous. However, whereas this degree of transcriptome and proteome heterogeneity is sufficient for defining cell subtypes, or even cellular states, is
also a topic of intense debate (Trapnell, 2015; Okawa et al, 2018). While single-cell RNAseq and mass cytometry allow to define molecularly distinct cell
subpopulations, these approaches require to be complemented by the identification of the unique functions associated with these cell populations, in
order to define those as cell (sub)types. Worth a notice, it is of importance not to confound cell subtypes with cellular states of reaction. The latter is refer-
ring to the different phenotypes and associated functions a cell type may acquire in response to various stimuli. A cell subtype should be defined by shared
properties/characteristics within other cells within the cell type. Their unique intrinsic features and selective physiological functions should also be indepen-
dent from their microenvironment. These two concepts are not mutually exclusive, as a cell subtype in response to a stimulus could react and acquire a new
phenotype, i.e., reaction states, thus adding another level of complexity. Microglial subtypes must be defined in steady-state and unchallenged conditions by
their intrinsic propertie(s) which translate into unique physiological function(s).
Typically, the existing literature is the foundation of a research plan, which by definition is biased in respect to studies aimed at identifying a new cell
type or subtype. This includes any work with markers, most importantly staining, sorting, and isolation of cells. Reverse genetic approaches can provide a
more reliable tool for such studies, but still they have inherit technical limitations such as cell gating in flow cytometry and antibody unspecificity (Luo
et al, 2013). On the other hand, unbiased technologies such as single-cell RNAseq, mass cytometry, and electron microscopy are useful tools, but still we
should be aware of their limitation in terms of providing a static view of cellular dynamics. They however become useful when combined with two-
photon in vivo imaging to provide insights into dynamics. Serendipitous identification is also an approach, but it is sporadic and by definition non-
systematic. All of the above methodologies can contribute to the identification of new microglial subtypes. Considering the various putative subtypes that
we have discussed in this review, a need for classifying microglial subtypes is evident. Deciphering whether their variations are instructed by the
microenvironment or whether they result from intrinsic properties is of prime importance, using the following methodological workflow: Fate-mapping
strategies allowing to visualize selectively different microglial subsets, for instance using non-invasive chronic two-photon in vivo imaging—could be
performed longitudinally across development, adulthood, and aging, under steady-state as well as disease conditions—to determine the identity of puta-
tive microglial subtypes as microglial subsets or phenotypes. Microglia could be considered subtypes if their defining properties remain when these cells
are examined longitudinally, under steady-state or disease conditions. They would however be considered phenotypes if instead they can transform one
into another, notably in response to stimuli. The molecular determinants and physiological roles of the distinct subsets could then be studied using a
combination of gene and protein expression analyses, as well as morphology, ultrastructure, and dynamic investigations.
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Figure 3. Putative microglial subtypes with unique specializations.
Emerging data provide support to the existence of putative microglial subtypes endowed with unique genomic, spatial, morphological, and functional specializations. We
anticipate that analyzing these subtypes thoroughly, with the methodological workflow proposed in Box 1, and using a similar methodology for newly discovered ones, will
result in the identification of a number of different microglial subtypes with unique functional characteristics that could be targeted for disease prevention or treatment.
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Similarly, differences in peripheral macrophage activation by LPS
and viruses have been described, where only a subset of the popula-
tion concomitantly displays a response (Ravasi et al, 2002). In addi-
tion, microglia may directly communicate with each other, which
suggests that the recruitment of a specific microglial cell might lead
to an inhibition of the neighboring microglia. Microglia were initially
defined as occupying non-overlapping territories in the healthy
brain, but this view is now changing, with improved staining meth-
ods showing direct contacts between processes and sometimes cell
bodies from neighbor microglial cells (for example, see Milior et al,
2016). Furthermore, the possibility that differential marker expres-
sion among adjacent microglia results from differences in microglial
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Figure 4. Toolbox.
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exposure to previous challenges also has to be considered. For
instance, it has been shown using non-invasive two-photon in vivo
imaging that neighbor microglia respond differently to laser injury in
the intact, unchallenged brain, leading to their processes converging
or not toward the site of injury (Nimmerjahn et al, 2005; Paris et al,
2018). In addition, microglial cell bodies were recently shown to
migrate in the cerebral cortex (Eyo et al, 2018) and cerebellum
(Stowell et al, 2018) of healthy adult mice, which paints another
layer of complexity. However, the existence of microglial subtypes,
each endowed with intrinsic differences in gene expression, cannot
be excluded and we argue that the topic deserves further investiga-
tion. Putative microglial subtypes are discussed below:
Keratan sulfate proteoglycan (KSPG)-microglia
A quarter of century ago, microglia were shown in the unchallenged
adult rat brain to exhibit constitutive heterogeneity in their expres-
sion of KSPG (Bertolotto et al, 1993), visualized in situ using the 5D4
monoclonal antibody (Fig 3). KSPG is located in the extracellular
matrix and on the cell surface. They are suggested to contribute to
the control of cellular adhesion and axonal growth. In particular,
5D4-KSPG is expressed by a subpopulation of ramified microglia,
contrary to ameboid microglia and peripheral macrophages (Ber-
tolotto et al, 1993, 1998). Of note, 5D4-KSPG expression does not
coincide with the expression of GFAP, NG2, or MAP2, which relate
to other CNS cells. The expression of 5D4-KSPG in microglia differs
significantly between strains of inbred rats (Jander & Stoll, 1996b).
In mammals, a subpopulation of 5D4-KSPG-expressing microglia
was also reported in the spinal cord and retina (Bertolotto et al,
1993, 1998; Jander & Stoll, 1996a; Jones & Tuszynski, 2002; Zhang
et al, 2005; Foyez et al, 2015). The 5D4-KSPG-microglia exhibit a
preferential regional distribution in the CNS. Indeed, whereas these
cells are found in large numbers among the hippocampus, brainstem,
and olfactory bulb (OB), only few of them are detected in the
cerebellum and cerebral cortex (Bertolotto et al, 1993, 1998). This
putative microglial subset is also observed in the neonatal rat brain
(Bertolotto et al, 1998). It is of importance to mention that 5D4-
KSPG-microglia were shown to co-exist with 5D4-KSPG-negative
microglia in the same CNS regions (Jones & Tuszynski, 2002).
Although these studies argue for the presence of two different subtypes,
based on KSPG-reactivity, a systematic approach is required to con-
firm this possibility (Fig 4).
Hox8b-microglia
These microglial cells have a molecular signature that differentiates
them from the canonical population, together with a unique spatial
and temporal distribution (see Box 2 for distinct ontogeny of Hoxb8-
microglia). Mice carrying the driver Hoxb8-Cre and the reporter
ROSA26-YFP alleles were crossed to trace YFP-Hoxb8 expression. In
the adult brain, the only cells showing YFP signal appeared to be
microglia. YFP-positive microglia were found throughout the brain,
especially in the cerebral cortex and OB (Chen et al, 2010; De et al,
2018; Fig 3). YFP-positive microglia, which represent 25–40% of the
total microglial population in the adult brain, were also shown to
co-exist with YFP-negative microglia (Chen et al, 2010; De et al,
2018; Nagarajan et al, 2018). Transcriptomic analyses comparing
Hoxb8-positive and Hoxb8-negative microglia revealed that they are
very similar at steady state, with only 21 genes differing signifi-
cantly in expression between the two populations (De et al, 2018).
Hoxb8-microglia express microglial signature genes, such as
Tmem119, Sall1, Sall3, Gpr56, and Ms4a7, and genes associated
with hematopoietic ontogeny including Clel12a, Klra2, and Lilra5 at
similar levels compared with non-Hoxb8 canonical microglia (Ben-
nett et al, 2018; De et al, 2018). Of note, neither of the two putative
microglial subtypes was found to expresses Hoxb8 in the adult
brain; instead, the lineage tracer approach revealed that Hoxb8 is
expressed by microglial progenitors prior to CNS infiltration (De
et al, 2018). Selective inactivation of Hoxb8 in the hematopoietic
system was also sufficient to induce pathological grooming behav-
ior, as observed in constitutive Hoxb8 mutant mice (Chen et al,
2010; Nagarajan et al, 2018). The strategy for gene deletion included
the use of Tie2 Cre mice that affect all hematopoietic cells and
endothelial cells (Chen et al, 2010). More cell-specific deletion of
Hoxb8 within microglial cells is a prerequisite to determine their
selective involvement in pathological grooming behavior.
CD11c-microglia
Recently, evidence for an additional microglial subtype expressing
the integrin CD11c was uncovered in neonatal mouse brain (Fig 3).
CD11c-microglia expand during postnatal development to represent
approximately one-fifth of the total microglial population at postna-
tal day(P)3-P5, and then drop to represent less than 3% of the popu-
lation in juvenile and adult mice (Wlodarczyk et al, 2017). Whether
this decrease in numbers is due to increased cell death, migration or
even trans-differentiation of this putative microglial subset is yet to
be determined. These microglia distribute unevenly across the
developing brain, being found predominantly in primary myelinat-
ing regions, mainly the corpus callosum and cerebellar white
matter. Gene ontology enrichment analysis revealed that CD11c-
microglia express genes associated with neurogenic and myelino-
genic processes in the neonatal brain. They are also a major source
of insulin-like growth factor 1 (IGF1), while selective depletion of
IGF1 in this microglial subtype leads to impaired developmental
myelination (Wlodarczyk et al, 2017). Thus, CD11c-microglia in the
neonatal mouse brain appear to play essential roles in neurogenesis
and myelinogenesis during development.
TREM2-microglia
There is additional evidence that differential microglial gene expres-
sion patterns define several microglial populations in the healthy
brain. For example, not all microglia express the cell surface recep-
tor TREM2, which is known to impact on their survival, prolifera-
tion, clustering around amyloid-beta (Ab) plaques in Alzheimer’s
disease (AD) pathology, phagocytosis, and metabolism (Yeh et al,
2017). Furthermore, loss-of-function variants in the TREM2 protein
increase the risk of developing late-onset AD among other forms of
dementia (Colonna & Wang, 2016). However, despite the apparent
essential function of TREM2 in microglia, its expression is far from
being ubiquitous and homogenous in those cells throughout the
brain. In the mouse brain, microglial expression of TREM2 also
varies between and within individual regions (Schmid et al, 2002).
The numbers of TREM2-expressing cells are highest in the cingulate
cortex and lateral entorhinal cortex, and much lower in the hypotha-
lamus and habenula, while some regions, such as the circumventric-
ular organs, completely lack TREM2 expression. Worth notice, even
in brain regions abundant in TREM2-expressing microglia, TREM2-
positive and TREM2-negative cells were found in the immediate
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vicinity to each other (Schmid et al, 2002). Regional differences in
TREM2 gene expression, associated with microglial markers, are
also observed in the human brain (Forabosco et al, 2013). Microar-
ray data generated from 101 healthy control individuals reveal
significant regional differences in TREM2 gene expression between
the white matter and cerebellum (Forabosco et al, 2013). This
regional heterogeneity in TREM2 expression could point toward a
specific subtype.
Microglia supporting neurogenesis
The use of CX3CR1-EGFP reporter mice, in which one of the loci of
fractalkine receptor Cx3cr1 is replaced by the gene encoding EGFP,
revealed heterogeneity of the microglial cell population within the
neurogenic subventricular zone (SVZ), and the adjacent rostral
migratory stream (RMS) that terminates into the OB (Ribeiro Xavier
et al, 2015; Xavier et al, 2015; Fig 3). First, it was noticed that micro-
glia located along the SVZ-RMS-OB axis are significantly less
ramified than microglia from adjacent areas in mice and rats
(Shigemoto-Mogami et al, 2014; Ribeiro Xavier et al, 2015; Xavier
et al, 2015). CX3CR1-EGFP expressing microglia were TREM2-nega-
tive, and about half of them also IBA1-negative in the SVZ and RMS
of wild-type adult mice. By contrast, CX3CR1-EGFP expressing
microglia expressed TREM2 in the OB of wild-type adult mice.
Further adding to this diversity, a subset of the latter population
additionally expressed CD68 (~35%) and/or isolectin B4 (~15%) in
the OB (Ribeiro Xavier et al, 2015). Significantly increased CD68
expression in microglia was also reported in the OB of adult wild-
type rats (Doorn et al, 2015), while a regional distribution of CD68-
positive microglia was reported in the brain of human midterm
fetuses (gestational ages of 15–25 weeks; Cho et al, 2013). As
observed in the SVZ and RMS, IBA1-negative and IBA1-positive
microglia were also observed in close vicinity to another within the
OB. Of note, the antigenic heterogeneity of CX3CR1-EGFP expressing
microglia was reported in later development among the SVZ of
newborn (P1) and early postnatal (P7) mice, suggesting persistence
of these microglial cell populations beyond ontogeny (Xavier et al,
Box 2 (with associated illustration): Revisiting the microglial origin(s)
An important question arising from the existence of microglial subtypes
relates to their possible origin(s). Do microglial subtypes possess intrinsic
differences prior to populating the CNS, or do they acquire their unique
properties once they have assumed their regional distribution within the
CNS parenchyma?
Current literature states convincingly that microglia derive from the first
wave of hematopoiesis from the embryonic yolk sac in mouse (Ginhoux
et al, 2010; Hoeffel et al, 2015; Perdiguero et al, 2015; Sheng et al, 2015;
Mass et al, 2016), where they follow a stepwise maturation program (Mass
et al, 2016; Matcovitch-Natan et al, 2016), before populating the embryonic
brain at E9.5 (Tay et al, 2017c). Based on the above literature, microglial
subtypes should differentiate once they have assumed their regional distri-
bution inside the CNS parenchyma (a). This hypothesis could explain micro-
glial differences resulting from regional differences in microenvironments
or from differences in local cues among the microenvironment such as
microglial interactions with different neuronal subtypes (inhibitory, excita-
tory) and glial cells (astrocytes, oligodendrocytes and their progenitors), or
slight differences in signaling thresholds, leading to the observed dif-
ferences in adjacent microglia. The alternative hypothesis which is based
on microglial cells exhibiting intrinsic differences prior to infiltrating the
CNS cannot be excluded at this early stage of investigation, and should be
tested (b and c). In support of the later hypothesis, Capecchi et al reported
that Hoxb8-microglia-progenitors already exist in the yolk sac at E8.5 (De
et al, 2018). Subsequently, these cells transit through the aorta-gonad-
mesonephros and fetal liver, where they expand in number, prior to their
entry into the brain at E12.5 (De et al, 2018) (c). On the same lines, micro-
glial cells found in CSF1R/ (Ginhoux et al, 2010; Erblich et al, 2011) and
in IL2-Tgfb1;Tgfb1/ (Keren-Shaul et al, 2017) transgenic mice are expected
to exhibit intrinsic differences prior to infiltrating the brain parenchyma.
Recently, it has been reported that at E14.5 two microglial subpopulations
exist, based on Ms4a7 expression (Hammond et al, 2018). It would be of
great interest to investigate the ontogeny of these two subpopulations. In
zebrafish, two waves of microglial infiltration have been reported (Xu et al,
2015; Ferrero et al, 2018). Microglia of a yolk-sac-equivalent structure origin
initially populate the embryonic brain. Subsequently, the microglial popula-
tion is replenished by adult microglia that derive from a distinct tissue later
during zebrafish development (d). This microglial diversity could result from
species-specific differences between zebrafish and mouse. Nevertheless,
these studies indicate that evolutionarily multiple microglial origins and
maturation programs are a possibility. Recently, it has been reported that
at steady state a wave of monocytes infiltrate the mouse brain parenchyma
at early postnatal stages; however, these cells were rapidly depleted and
did not contribute to the later microglial population (Askew et al, 2017).
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2015). In addition, at those developmental ages, CD68 expression
was detected in a microglial subset only. It would be of particular
interest to determine whether the CD68-expressing microglia found
in the OB of adult mice originate from the ones detected in the SVZ
of newborn mice and whether the microglial heterogeneity described
above translates into one or more microglial subtypes during adult-
hood and aging. A recent study has taken advantage of single-cell
RNAseq analysis to uncover regional microglial heterogeneity across
different brain regions (Li et al, 2019). Contrary to expected, the
authors found a remarkable homogeneity of adult homeostatic
microglia (enriched in homeostatic genes such as TMEM119 or
P2ry12) regardless of the brain tissue of origin. However, a micro-
glial population expressing Clec7a, one of the most upregulated
genes in DAM (Keren-Shaul et al, 2017; Krasemann et al, 2017), was
shown by immunohistochemistry to be restricted to the subgranular
zone of the hippocampal dentate gyrus, another neurogenic niche, in
addition to the SVZ and RMS. This restrictive pattern of localization
suggests the existence of a microglial subtype that exerts a key role
in adult neurogenesis. These findings illustrate the usefulness of
combining different methodological strategies to uncover novel
microglial populations among specific CNS regions.
These selected examples of differential gene expression among
small populations of microglia argue for the existence of distinct
microglial subtypes. Of importance, in the majority of these cases,
the putative microglial subtypes co-existed with canonical microglia
within the same microenvironment. While extrinsic factors such as
local cues in the microenvironment, as discussed above, could
determine this variability, microglia also appear to have intrinsic dif-
ferences that warrant further investigation.
Single-cell RNAseq data
Recently, there has been an unprecedented influx of data from
single-cell RNAseq studies in support of a significant microglial
heterogeneity. Although at this point these pieces of evidence are
descriptive and we suggest that they have to be coupled with func-
tional studies to categorize the identified clusters as different micro-
glial subtypes, it is striking to report such a plethora of different
potential microglial subtypes. In particular, Stevens and colleagues
performed deep single microglial cell RNAseq at different develop-
mental stages and uncovered eight transcriptionally distinct micro-
glial clusters co-existing in the naı¨ve mouse brain (Hammond et al,
2018). Among them, “cluster 2” is characterized by a high expres-
sion of Ms4a family members, some of which are involved in
immune cell functions (Eon Kuek et al, 2016), and partially overlaps
with brain border macrophage markers (Hammond et al, 2018).
The number of cells belonging to “cluster 2” decreases drastically
during postnatal development. “Cluster 3” is almost exclusively
found in the embryonic and early postnatal brain. It is characterized
by its unique expression of Fabp5, while “cluster 6” highly
expresses genes that include Cd74, Ccl24, and Arg1 and is enriched
in female samples (Hammond et al, 2018). “Cluster 4” [named
axonal tract-associated microglia (ATM) by the authors] has a very
specific spatiotemporal expression. Microglia belonging to this clus-
ter highly express Spp1, Gpnmb, Igf1, CD68, and Lgals3, and they
have an ameboid morphology. Furthermore, their number is signifi-
cantly enriched in the neonatal brain and they are preferentially
localized in the white matter, including the corpus callosum, and
cerebellum (Hammond et al, 2018).
Proliferative-region-associated microglia (PAM)
Similarly, Barres and colleagues performed deep single microglial
cell RNAseq at different developmental stages including late embry-
onic, early postnatal (P7) and adult ones across different brain
regions (Li et al, 2019). Three well-defined microglial clusters irre-
spective of cell cycle states were identified during postnatal devel-
opment (Li et al, 2019) and initially named P7-C0, P7-C1, and P7-
C2. The P7-C0 and P7-C1 microglial clusters both expressed home-
ostatic genes although at lower levels for P7-C1. This specific clus-
ter expressed many genes recently identified in DAM including
Igf1, Spp1, Gpnmb, CD11c (also known as Itgax), and Clec7a
(Keren-Shaul et al, 2017; Krasemann et al, 2017). Further analysis
identified these cells to be predominantly located in the corpus
callosum and cerebellar white matter, where they intermingled
with Mbp+ oligodendrocytes; hence, they were named the prolifer-
ative-region-associated microglia (PAM). These PAM are highly
reminiscent of the CD11c-microglia described by Wlodarczyk et al
(2017) (Wlodarczyk et al, 2017) and the ATM cluster identified by
Hammond et al (2018). Indeed, PAM populate the white matter at
P4, peak at P7, and almost disappear by P14. At the morphological
level, PAM are ameboid with thicker primary branches and larger
cell bodies, as compared with the typical microglia. They are also
highly phagocytic, and contrary to the DAM, they do not depend
on either triggering receptor expressed on myeloid cells 2 (TREM2)
or ApoE (Keren-Shaul et al, 2017; Krasemann et al, 2017).
Although it is clear that postnatal PAM may represent a specialized
microglial subtype involved in the elimination of oligodendrocytes
during myelination, the exact timing and appearance of this micro-
glial population in the white matter during periods of myelination
indicates that the environmental needs may be behind the polariza-
tion of homeostatic microglia toward PAM.
In a third study, Prinz and colleagues (Masuda et al, 2019)
analyzed single microglial cells derived from brain areas that were
previously shown to exhibit regional transcriptional differences
(Grabert et al, 2016), namely cortex, cerebellum, and hippocampus,
and additionally analyzed microglia from corpus callosum. Microglia
from juvenile (3 weeks old) and adult (16 weeks old) animals were
grouped into at least four distinct clusters which showed a variable
distribution between brain regions and developmental stage (Masuda
et al, 2019). Importantly, this study also identified multiple different
microglial clusters in human tissue, from cortex that bears no signs of
CNS pathology (Masuda et al, 2019), therefore indicating that micro-
glial heterogeneity is also relevant to human (see also later).
Microglial subtypes as defined by differential structural/
ultrastructural properties
Returning to the satellite microglia described by Rı´o-Hortega
(1919b), this subpopulation is currently identified based on its
unique feature of having its soma being associated with neuronal
cell bodies (Baalman et al, 2015; Wogram et al, 2016; Fig 3). Half
of the satellite microglia extend a single process that overlaps with
the portion of the axon where potentials are initiated (Baalman
et al, 2015). They have been identified both during development
and at adulthood in mice, while they have a preferential association
with excitatory neurons (Baalman et al, 2015). In addition, this
subpopulation was reported in the cerebral cortex of adult rats and
adult non-human primates (Rı´o-Hortega, 1919b; Baalman et al,
2015), hence indicating conservation across species. Whether
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satellite microglia represent a transitional state of “surveilling”
microglia or bear intrinsic differences compared to their neighbor-
ing microglia is yet unknown, as no specific “satellite” microglial
marker has been identified and transcriptomic analysis of this
microglial subpopulation was not performed. Yet, they are preferen-
tially located in the cerebral cortex (~8% of cortical microglia) as
well as hippocampus, and to a lesser degree in the thalamus and
striatum (Baalman et al, 2015; Wogram et al, 2016), suggesting that
they perform a specialized function. Interestingly, in the adult
mouse cerebellum, a dynamically unique population of “satellite”
microglia was recently described using non-invasive two-photon
in vivo imaging (Stowell et al, 2018). These cells display migration
of their soma, which interact with both Purkinje neuronal cell
bodies and proximal dendrites. These cerebellar microglia are also
less ramified than their cortical counterparts and show reduced
surveillance. This finding indicates that satellite microglia are
heterogeneous in their dynamics under steady-state conditions.
In addition to the distinct microglial morphological properties
that were revealed by light or fluorescence microscopy, the use of
high spatial-resolution electron microscopy (EM) uncovered along-
side to the typical microglia the occurrence of microglia filled by
cellular debris, akin to the fat granule or gitter cells initially
described by Rı´o-Hortega (1920), during aging, age-related loss of
sensory function, and Werner syndrome in mice (Tremblay et al,
2012; Hui et al, 2018b). Recently, EM also allowed to identify an
ultrastructurally distinct microglial population, the “dark” microglia,
in the adult and aged mouse hippocampus (CA1 region and dentate
gyrus), cerebral cortex, amygdala, and hypothalamus. These cells
co-existing with the canonical population display several ultrastruc-
tural features of microglia, particularly their size, morphology, long
stretches of endoplasmic reticulum, interactions with neurons and
synapses, and association with the extracellular space. However,
contrary to the typical microglia, they also display markers of oxida-
tive stress like a condensed, electron-dense cytoplasm and nucleo-
plasm, giving them a dark appearance in EM, accompanied by Golgi
apparatus/endoplasmic reticulum dilation, mitochondrial alteration,
and a partial to complete loss of heterochromatin pattern (Bisht
et al, 2016; Hui et al, 2018a). In neurons, alterations to the hete-
rochromatin pattern are linked to cellular stress, aging, and brain
disorders such as schizophrenia and AD (Medrano-Ferna´ndez &
Barco, 2016).
The physiological significance of these dark microglia has yet to
be elucidated, but they appear to be extremely active. The hundreds
of dark microglia examined with EM contacted several synaptic
elements with their highly ramified and extremely thin processes
(Bisht et al, 2016). They generally reached for synaptic clefts, while
encircling pre-synaptic axon terminals as well as postsynaptic
dendrites and spines. By comparison, typical microglia focally
contact instead of encircle synapses (Tremblay et al, 2010). Three-
dimensional reconstructions will be required to determine whether
the contacted synaptic elements are completely internalized and
phagocytosed by the dark microglia, stripped, or encircled and
digested extracellularly. Another distinctive feature of these cells is
their frequent association with capillaries, with their processes
ensheathing the basal lamina. 52% of the dark cells apposed one
capillary, and 13% contacted capillaries simultaneously (Bisht et al,
2016). This could suggest a possible implication in vascular remod-
eling or in maintenance of the blood–brain barrier. In fact, recent
ultrastructural investigations confirmed a participation of microglial
cells, which resemble dark microglia in terms of localization while
displaying different ultrastructural features, in the formation of the
glia limitans of arteries, capillaries, and veins (Joost et al, 2019).
Surprisingly, the dark microglia were also discovered to be abun-
dant during normal brain development, reaching a maximal density
approximating 30 cells/mm2, in the first two postnatal weeks when
synaptic pruning is most pronounced, both in the cerebral cortex
and in the hippocampus [(Bisht et al)—unpublished observations].
The dark microglia downregulate IBA1, CX3CR1, and P2RY12, but
strongly express CD11b, which forms complement receptor 3
involved in microglia-mediated synaptic pruning (Stevens et al,
2007; Schafer et al, 2012), in their processes encircling synaptic
elements (Bisht et al, 2016). They are also negative for MHC class
II, CD206, and CD11c. In support of a microglial origin, the dark
microglia do not express the marker of inflammatory monocytes
4C12 and show a strong immunoreactivity against the marker of
phagocytic microglia 4D4 on their distal processes (Bisht et al,
2016). They were observed in CCR2 knockout mice (Bisht et al,
2016), where the recruitment of peripheral monocytes to the brain
is impaired (Mildner et al, 2007).
Microglial response to stimuli/pathological changes
Microglial subtypes can respond differently to one stimulus
Different subpopulations, and potentially subtypes, of microglia in
the CNS, have been reported to respond differently to an identical
stimulus, or to be differently affected by injuries or diseases
affecting the CNS. As an illustration, LPS stimulation results in the
induction of TNF-a or inducible nitric oxide (NO) synthase (NOS2)
expression only in a subpopulation of microglia ex vivo and in vivo
(Scheffel et al, 2012; Kiyofuji et al, 2015). Besides, only a subset of
cultured primary rat microglia survive to an LPS challenge, an effect
that is related to the self-production of granulocyte-macrophage
colony-stimulating factor (GM-CSF) and upregulation of its receptor
GM-CSFR (Kamigaki et al, 2016). Recently, Furube et al (2018)
further reported that the administration of LPS in the circumventric-
ular organs affects microglial proliferation locally and in neighbor-
ing regions, but not in the cerebral cortex. Thus, microglia respond
unequally to an LPS challenge.
In vivo experiments in rodents have shown that various periph-
eral inflammatory stimuli can affect microglial morphology, gene
expression, and/or function in the brain (Hoogland et al, 2015).
Hence, it is reasonable to speculate that microglial heterogeneity
could also be influenced by the periphery. Neher and coworkers
recently demonstrated that peripherally applied inflammatory stim-
uli which induce either acute immune training (e.g., single intraperi-
toneal injection of LPS) or tolerance (e.g., daily injections of low-
dose LPS on 4 consecutive days) in the brain lead to differential
epigenetic reprogramming, associated with unique transcriptome
profiles of microglia that persist for at least half a year (Wendeln
et al, 2018). Epigenetic changes, including histone modifications or
DNA methylation as well as microRNA expression, are important
modifiers of gene expression, and have been involved in cell pheno-
type regulation and reprogramming and are therefore part of the
mechanisms regulating cellular plasticity including microglia
(Cheray & Joseph, 2018). These two types of immunological
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imprinting, i.e., training and tolerance, were shown to impact on
the microglial responses to subsequent disease-associated stimuli,
such as b-amyloidosis or ischemia (Wendeln et al, 2018). Worth a
note, the authors noted that in that context the global epigenetic
and transcriptional changes were relatively modest, and proposed
that they might originate from a small number of microglia.
Whether this restricted responsive microglial population reflects a
limited number of microglial cells that received the required
secondary stimulus or the response of microglial subtype(s) show-
ing a different response threshold remains to be explored.
Microglial subtypes can respond differently to signal withdrawal
and depletion attempts
The class III transmembrane receptor tyrosine kinase, CSF1R, is a
key regulator of myeloid cell proliferation, survival, and functions
(Dai et al, 2002; Ginhoux et al, 2010; Erblich et al, 2011; Elmore
et al, 2014). CSF1R can be activated by ligation of colony-stimulating
factor 1 (CSF1) and interleukin (IL)-34. Despite the fact that CSF1
and IL-34 share affinity for the same receptor, their biological func-
tions do not strictly overlap, as revealed by their distinct spatiotem-
poral brain expression patterns, the different impact of their gene
deletion, and the cellular responses observed upon their binding to
CSF1R (Chihara et al, 2010; Nandi et al, 2012; Wang et al, 2012).
In the brain, although CSF1R is primarily expressed by microglia,
a subset of hippocampal and cortical neurons were reported to also
express this receptor (Wang et al, 1999; Luo et al, 2013). Homozy-
gous null mutation of the CSF1R gene in mice results in a repro-
ducible and robust, yet not complete, loss of myeloid cells defined
by their expression of CD45/CD11b/F4/80 markers (Ginhoux et al,
2010), and IBA1- and F4/80-double-positive cells displaying an
ameboid morphology (Erblich et al, 2011). Similarly, recent post-
mortem human brain examination of a 10-month-old individual
carrying a homozygous missense mutation in the CSF1R gene
revealed a dramatic reduction in IBA1-positive cells in the brain.
Nonetheless, there was a residual IBA1-positive cell population with
an ameboid morphology that was located mainly around blood
vessels (Oosterhof et al, 2019). Whether this residual population is
conclusively microglia requires further investigation.
CSF1R inhibitors (e.g., PLX5622 and AFS98) have been used to
deplete microglia (Han et al, 2017). These inhibitors have proved very
efficient at robustly reducing microglial numbers in adult mice;
however, upon treatment cessation microglia rapidly repopulate the
brain parenchyma. Although the mechanisms underlying this repopula-
tion are still under investigation, it was recently shown that residual
microglia are the only source of repopulation upon PLX5622 treatment
(Huang et al, 2018b). Similarly, administration of AFS98 at E6.5 and
E7.5 (when yolk-sac erythro-myeloid progenitors are generated) is suffi-
cient to deplete macrophages in the E10.5 yolk sac, as well as microglia
at E10.5 and E14.5. The depletion is transient with microglia repopulat-
ing the brain parenchyma partially around E17.5 (Hoeffel et al, 2015),
and fully during the first postnatal weeks (Squarzoni et al, 2014). The
above findings argue for a subset of microglia that might not fully
depend on CSF1R stimulation for its maintenance. As further illustra-
tion, a recent report indicates that upon microglial depletion with
PLX5622, the central cornea is repopulated by a subpopulation of
microglia which resides in the optic nerve (Huang et al, 2018a).
In addition to CSF1R signaling, TGFb1 has been identified as a
major differentiation and survival factor for the microglial cell
population. In particular, IL2-Tgfb1;Tgfb1/ transgenic mice, lack-
ing TGFb1 expression in the CNS, while retaining its expression in T
lymphocytes, show a robust loss of microglia, although a microglial
subpopulation exhibiting an ameboid morphology, contrary to
microglia in age-matched wild-type mice, persisted upon this CNS
TGFb1 deficiency (Butovsky et al, 2014).
Microglial heterogeneity in disease conditions
The 5D4-KSPG-microglial population described above is influenced
by pathology. In particular, 5D4-KSPG expression is increased selec-
tively in a subset of IBA1/CD11b-positive microglia in the SOD1G93A
mouse model and human cases of amyotrophic lateral sclerosis (ALS;
Hirano et al, 2013; Foyez et al, 2015), and in a Wallerian degenera-
tion mouse model of spinal cord injury (Shinjo et al, 2014), while it
decreases in a Guillain–Barre´ syndrome rat model of experimental
autoimmune neuritis (Matsui et al, 2013). Mice deficient in N-acetyl-
glucosamine 6-O-sulfotransferase-1 (GlcNAc6ST-1), an enzyme
involved in 5D4-KSPG biosynthesis, also show reduced 5D4-KSPG
expression in the CNS (Zhang et al, 2006). Remarkably, SOD1G93AGlc-
NAc6ST-1/ mice exhibit a significantly reduced lifespan and accel-
erated clinical symptoms as compared to SOD1G93A mice (Hirano
et al, 2013; Foyez et al, 2015), suggesting that 5D4-KSPG-microglia
which expand in SOD1G93A mice may play a beneficial suppressive
role in the early pathogenic phases of ALS (Hirano et al, 2013).
In addition, the dark microglia which are rarely observed in
healthy young adult mice became highly prevalent upon chronic
stress, aging, fractalkine signaling deficiency (in CX3CR1 knockout
mice), and AD pathology (APP/PS1 model). Signaling between the
neuronal fractalkine (CX3CL1) and its unique receptor, CX3CR1,
expressed by microglia, is a main mode of neuron–microglia commu-
nication in the brain (Paolicelli et al, 2014; Arnoux & Audinat, 2015).
The number of dark microglia in the hippocampus quadruples in
young adult mice after 2 weeks of chronic unpredictable stress as
compared to counterparts housed under control conditions. In the
CX3CR1 knockouts exposed to stress, the dark microglial population
reached approximately half of the typical microglial population.
These cells also became more prevalent during normal aging, at
14 months which corresponds to middle age in mice, where their
density tripled compared with young adulthood (3 months of age). In
age-matched APP/PS1 littermates, the number of dark microglia
corresponded to almost two-thirds of the typical microglial popula-
tion (Bisht et al, 2016).
In the APP/PS1 mice, the dark microglia associated with Ab or
neuronal dystrophy were TREM2 positive. These dark microglia
frequently contained fibrillary Ab and encircled synaptic elements
displaying signs of dystrophy, including an accumulation of autop-
hagic vacuoles. In adult offspring exposed to maternal immune acti-
vation and displaying schizophrenia-like behavior, dark microglial
numbers tripled those in 14-month-old APP/PS1 mice (Hui et al,
2018a). Interestingly, both the schizophrenia-like behavior and
prevalence of dark microglia were exacerbated in males mice (Hui
et al, 2018a), suggesting sexual dimorphism in these cells. These
overall findings suggest that dark microglia could represent a micro-
glial subtype that exerts specialized functions across development,
stress-induced plasticity, and disease. The physiological roles and
molecular determinants of these microglial cells warrant further
investigation. Fate-mapping strategies will be required to determine,
using non-invasive longitudinal two-photon in vivo imaging,
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whether typical microglia can transform into dark microglia under
adaptive pressure, or whether the typical and dark microglia repre-
sent distinct subsets already from the developmental stages.
Plaque-associated microglia illustrate how a specific disease-asso-
ciated microenvironment can result in the emergence of different
microglial phenotypes (or subtypes). In addition to the dark micro-
glia, an age-dependent increase in CD11c-labeled microglia is associ-
ated with Ab plaques burden in different models of AD, including
CVN-AD (Kan et al, 2015) and APP/PS1 (Kamphuis et al, 2016)
mice. A characteristic feature of these microglial “types” is their high
expression levels of Igf1 (Kan et al, 2015; Kamphuis et al, 2016),
which is reminiscent of the recently defined CD11c-microglia
involved in myelination and neurogenesis during development (Wlo-
darczyk et al, 2017), the ATM (Hammond et al, 2018), and PAM (Li
et al, 2019). These observations suggest the existence of distinct
microglial subtypes that emerge to exert specialized physiological
functions during specific stages of development and that can also be
recruited during pathological conditions when there is a need for
such functions. Given the role that CD11c-microglia play in myelina-
tion in the healthy brain, their presence in demyelinating diseases
was expected. In different studies, indeed, the occurrence of a similar
CD11c-microglial population was demonstrated in mouse models of
demyelination, such as cuprizone (Remington et al, 2007; Wlodar-
czyk et al, 2015), experimental autoimmune encephalomyelitis
(EAE; Wlodarczyk et al, 2014, 2015), and neuromyelitis optica-like
pathology (Wlodarczyk et al, 2015). It is important to note that there
is no definite proof that disease-associated CD11c-microglia arise
from the population of CD11c-positive microglia found in the neona-
tal mouse brain. When technically possible, performing lineage trac-
ing of the initial CD11c-microglial subtype into adulthood, at steady
state and upon demyelination, would be very informative.
However, some clues about the origin of these cells may come
from recent investigations that identified a microglial signal regulatory
protein a (SIRPa)-dependent signaling pathway that controls the
expansion of CD11c-microglia in adult mice (Sato-Hashimoto et al,
2019). Genetic ablation of this membrane protein SIRPa (including
selectively in microglia) or of CD47, a physiological ligand of SIRPa,
results in the emergence of CD11c-microglia in the white matter of
adult mice, thus suggesting that the CD47-SIRPa signaling pathway
normally represses the activation of CD11c-microglia. A small resident
CD11c-microglial population was also reported in the normal adult
mouse brain (Bulloch et al, 2008; Sato-Hashimoto et al, 2019).
However, genetic ablation of SIRPa in this small subset of resident
CD11c-microglia only, which was obtained by crossing SIRPa-flox
mice and CD11c-Cre mice, does not promote the expansion of the
CD11c-microglial population in adult mice. These data suggest that
the increased number of CD11c-microglia, at least in mice deficient for
the CD47–SIRPa-signaling pathway, is not due to the expansion of the
resident CD11c-microglial subset, but instead likely results from the
acquisition of CD11c expression in microglia that were initially nega-
tive for it. Nevertheless, it is important to notice that multiple signal-
ing pathways can control the expansion or emergence of CD11c-
microglia. Indeed, in the CNS, CSF1R stimulation by its ligands, i.e.,
IL-34 or CSF1, coincides with the expansion of CD11c-microglial popu-
lation. Treatments with these CSF1R ligands also appear to reduce
both demyelination and symptoms in EAE mouse model (Wlodarczyk
et al, 2018). However, as it was performed for the CD47–SIRPa-
signaling pathways, it remains to be explored whether this
CSF1R-dependent signaling pathway could impact on the expansion
of the resident CD11c-microglial population observed at adulthood.
Developing and demyelination-associated CD11c-microglia share
transcriptomic similarity, but they are far from being identical (Kan
et al, 2015; Kamphuis et al, 2016; Keren-Shaul et al, 2017; Krase-
mann et al, 2017; Wlodarczyk et al, 2017; Hammond et al, 2018; Li
et al, 2019). Whether these transcriptomic differences define two
distinct populations of CD11c-microglia, or differences due to the
stage of the lifespan and the particular context of health or injury, for
a unique CD11c-microglial subtype, remains unanswered. Further-
more, recently Stevens and colleagues identified and reported the
expansion of a Ccl4-microglial subset upon aging and injury (Ham-
mond et al, 2018).
Recent studies have exploited massive transcriptomic analyses to
uncover microglial reaction states associated with homeostatic
(Butovsky et al, 2014; Bennett et al, 2016), aging (Hickman et al,
2013; Grabert et al, 2016; Galatro et al, 2017), or disease-associated
(Orre et al, 2014; Keren-Shaul et al, 2017; Krasemann et al, 2017;
Mathys et al, 2017) conditions. Transcriptional profile studies of
microglia isolated from models of aging and different neurodegenera-
tive diseases demonstrated a strikingly similar transcriptional
network across these conditions. For instance, two recent studies
performing single-cell RNAseq of microglia (isolated as discussed
below) in mouse aging and models of AD, multiple sclerosis, and
ALS, defined a distinctive microglial molecular signature of disease
defined as (DAM; Keren-Shaul et al, 2017) or “microglia neurodegen-
erative phenotype” (MgND; Krasemann et al, 2017), suggested to be
driven by TREM2. This apparent simplicity in the switch from home-
ostatic microglia to a common disease-associated phenotype, even in
response to varied conditions of altered microenvironment, suggests
that the disease-associated phenotype program may represent a prim-
ing response against more specific challenges. Using mass cytometry
which allows to investigate changes in microglial proteome, at the
single-cell level, a similar “disease-associated” microglial phenotype
was recently described in aging and AD pathology (APP/PS1 mice;
Mrdjen et al, 2018). These cells displayed increased expression of
CD14, a co-receptor of the Toll-like receptor 4, that is activated by Ab
and pro-inflammatory cytokines such as TNF-a (Mrdjen et al, 2018).
While the disease-associated program is inherently linked to AD
pathology (derived from the use of 5xFAD or APP/PS1 transgenic
mice), a recent report by Mathys et al (2017) also revealed that this
microglial molecular signature may proceed in a heterogeneous fash-
ion. CK-p25 mice rapidly develop AD-associated features ranging from
neuronal DNA damage and Ab accumulation (2 weeks after p25
induction) to progressive neuronal and synaptic loss, as well as cogni-
tive impairment (already severe 6 weeks after p25 induction). The
short time window allowed to identify microglial populations associ-
ated with early-stage and late-stage responses. Analysis of the tran-
scriptional dynamics of late response microglia identified small
subsets of single cells upregulating specific gene sets, including antivi-
ral and interferon response genes and components of the MHC class II
pathway, which displayed extensive variability (Mathys et al, 2017).
The authors concluded on the existence of two distinct disease-asso-
ciated microglial subpopulations. Since the DAM program, described
by Keren-Shaul et al (2017), was not associated with changes in
antiviral and interferon response genes, different disease-associated
microglial “subtypes” might be behind these different findings.
However, CK-p25 mouse is an AD model of severe neurodegeneration
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in contrast to the 5xFAD and APP/PS1 models originally used for the
identification of DAM (Keren-Shaul et al, 2017; Krasemann et al,
2017; Mathys et al, 2017). As a model of severe neurodegeneration,
the CK-p25 mouse exhibits important cell-associated DNA damage, a
well-known inducer of type 1 interferons (Ha¨rtlova et al, 2015), which
may underlie the specific changes in antiviral and interferon response
seen by Mathys et al (2017).
Further evidence was recently provided by Tay et al (2018)
performing single-cell RNAseq analysis of microglia following facial
nerve axotomy at different temporal stages of the disease (i.e., peak
and recovery) in adult mice. The authors identified a unique TREM2-
independent microglial subtype at the onset of recovery, which
upregulated ApoE and Ccl5, in addition to showing ameboid and
anucleated morphologies. Additionally, mass cytometry was used to
investigate the changes in signaling and cytokine molecular signa-
tures of microglia in three disease contexts: Huntington’s disease
(HD), EAE, and ALS (Ajami et al, 2018). Although defined as rela-
tively homogeneous by common cell surface markers, microglia in
fact contain heterogeneous functional subsets based on their cyto-
kine secretion profile. In particular, two distinct cytokine-secreting
microglial subsets that represent the signature of neuroinflammatory
conditions, compared with neurodegeneration models, were identi-
fied. Although both neuroinflammatory and neurodegenerative
models developed double-positive TNF-a- and GM-CSF-producing
cells, this subset abundance correlated best with the height of
neuroinflammatory conditions in EAE—peak and onset, whereas it
was extremely rare or absent in both models of HD and ALS. Conver-
sely, both neurodegenerative conditions showed a unique subset of
cells expressing IL-10, often considered an anti-inflammatory cyto-
kine, across all three CNS-resident myeloid populations (i.e., micro-
glia, meningeal macrophages, and perivascular macrophages) before
late-stage disease symptoms (Ajami et al, 2018). Using single-cell
RNAseq of CD45-positive cells, Prinz and colleagues have recently
demonstrated an apparent microglia and CAM diversity under dif-
ferent disease conditions including EAE, cuprizone-induced demyeli-
nation, and unilateral facial nerve axotomy (Jorda˜o et al, 2019;
Masuda et al, 2019). Especially relevant was the microglial hetero-
geneity associated with multiple sclerosis, a view that was confirmed
in both experimental mice and humans (Jorda˜o et al, 2019; Masuda
et al, 2019). Thus, three different microglial subsets linked with the
EAE-associated lesion sites were identified in mice and termed
daMG2, daMG3, and daMG4 (Jorda˜o et al, 2019). A common feature
in the three subtypes differing in the expression of specific chemoki-
nes, cytokines, and cysteine proteases was their downregulation of
the homeostatic markers P2RY12 and TMEM119. In particular,
daMG2 showed strong upregulation of CD74, Ctsb, and Apoe,
whereas daMG3 showed high levels of Cxcl10, Tnf, and Ccl4 and
daMG4 of Ccl5, Ctss, and Itm2b (Jorda˜o et al, 2019). Remarkably,
the Prinz team performed scRNAseq from brains of patients with
multiple sclerosis and analyzed together with healthy human brains
(Masuda et al, 2019). This study identified three different clusters
associated with homeostatic microglia highly expressing TMEM119
and P2RY12. Three microglial clusters were associated with multiple
sclerosis (Hu-C2, Hu-C3, and Hu-C8), thus mimicking and validating
the data obtained using the mouse models. Common features of the
three clusters were increased expression of Apoe and MAFB along
with downregulation or even absence of microglial core genes
(Jorda˜o et al, 2019). These studies support the challenging view that
different microglial subtypes may change their phenotypes to gener-
ate context- and time-dependent subtypes (as depicted in Fig 2).
A successful isolation of microglia appears critical to identify
microglial subtypes. Recent studies aimed at characterizing the
molecular signature of microglia at the single-cell levels under
disease conditions using FACS, with different sorting strategies based
on either CD45 or CD11c (Keren-Shaul et al, 2017), FCRLS/CD11b or
FCRLS/Clec7a (Krasemann et al, 2017) or CD11b/CD45 (Mathys
et al, 2017; Li et al, 2019) or CD45, CD11b, and Cx3cr1 (Hammond
et al, 2018) or CD45, CD11b, Ly6C, and CD206 (Masuda et al, 2019).
However, positive selection based on “pan-microglial” markers
accepts that such markers exist. Of note, the widely used “pan-
neuronal” marker NEUN and the “pan-astrocytic” marker GFAP are
not expressed in all neurons (Gusel’nikova & Korzhevskiy, 2015)
and astrocytes (Walz & Lang, 1998), respectively. Recent studies
have successfully isolated microglia by non-invasive methods such
as RiboTag, single nuclei sequencing, and TRAP (Ayata et al, 2018;
Haimon et al, 2018). These methods preclude non-specific microglial
reactivity, associated notably with the induction of immediate early
and pro-inflammatory genes, during FACS-based whole single-cell
isolation (Ayata et al, 2018; Haimon et al, 2018; Li et al, 2019). The
RiboTag and TRAP approaches require the usage of mice that
express Cre recombinase under the control of a microglia-specific
gene promoter. Thus, Cx3cr1Cre has been shown to target neurons
and tamoxifen-based Cx3cr1CreER mice target not only microglia,
but also non-parenchymal macrophages (Goldmann et al, 2016).
This limitation is especially relevant under disease conditions associ-
ated with blood–brain barrier disruption. However, whole-cell tran-
scriptomes are usually contaminated by artifacts inherent to tissue
dissociation, by phagocytosed material, and by transcripts seques-
tered away from ribosomes. These limitations of FACS-based cell
strategy are, on the other hand, a strength when performing
RiboTag, single nuclei sequencing, or TRAP. Consequently, each
technology has its strengths and weaknesses that should be carefully
evaluated when facing the experimental design. Each of them along
with complementary technology like mass cytometry, successfully
employed for identification of signaling and cytokine molecular
signatures of microglia under disease conditions (Ajami et al, 2018),
will help in the better understanding of the microglial diversity.
We conclude this section with the importance of unraveling the
functional roles exerted by microglia in diseases and aging, and to
develop for this purpose efficient microglial isolation procedures, as
required for cutting-edge single-cell RNAseq and mass cytometry. At
present, there is even uncertainty as to whether the roles of micro-
glia are protective or deleterious, which may depend on subtype,
and vary along CNS regions, stages of the lifespan, and contexts of
disease. Interestingly, single-cell RNAseq has been shown, depend-
ing on the analysis depth, to detect only abundant transcripts (Peter-
son et al, 2017). Several transcripts and proteins of the DAM did not
overlap (Keren-Shaul et al, 2017; Mrdjen et al, 2018), while a
marked dissociation of mRNA and protein networks was described
in microglia exposed to LPS challenge (Boutej et al, 2017). It should
be noted also, on a positive note, that mass cytometry data could be
useful for instructing isolation procedures, through the identification
of cell surface markers that can be used (Mrdjen et al, 2018).
Complementary techniques that should be considered for investigat-
ing microglial subtypes, in order to reduce the influence of micro-
glial isolation procedures on their phenotypic transformation, are
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RiboTag, TRAP, and single nuclei sequencing. Here, changes in
translating ribosomes—thus preventing artifacts introduced by
tissue dissociation, cargo contamination, and transcripts seques-
tered from ribosomes (Haimon et al, 2018)—and nuclei—which
does not require tissue dissociation and can be performed on fresh-
frozen or lightly fixed samples (Habib et al, 2017)—are selectively
investigated among microglia. Multiple approaches are indeed
needed to reveal changes in gene and protein expression, and ulti-
mately function, to solve this exciting mystery.
Summary and conclusion
The existing literature provides compiling evidence that several
microglial subtypes could co-exist within the CNS. Microglial
heterogeneity in terms of regional differences directed by the
microenvironment has been proposed before (McCluskey & Lamp-
son, 2000; Olah et al, 2011; Hanisch, 2013; Gertig & Hanisch, 2014),
but was overshadowed by a more restrictive one-microglial popula-
tion view. Here, we propose the existence of microglial subtypes
that bear intrinsic differences and we suggest methodological tools
that could lead to the identification, classification, and study of
putative microglial subtypes. Our recommendations for the investi-
gation of microglial subtypes are presented in Fig 4.
In summary, we should aim at playing with the full deck of micro-
glial subtypes’ cards (Fig 3), which will tremendously help us in our
understanding of microglial biological functions and provide us with
the tricks required to selectively act on selected subtype(s), and
thereby obtain the desired effect from manipulating selected card(s)
and not the whole deck. Considering that different microglial cells
can exert various functions under normal physiological conditions,
depending on their regional distribution, gene, and protein expres-
sion, a better understanding of microglial diversity (made of pheno-
types and perhaps subtypes also) is required for the future
development of better-targeted therapies for a variety of disease
conditions in which these cells were shown to be involved.
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